L1 Cell Adhesion Molecule Expression Is Associated With Pelvic Lymph Node Metastasis and Advanced Stage in Diabetic Patients With Endometrial Cancer: A Matched Case Control Study|RISS 상세보기

다국어 초록 (Multilingual Abstract)

Background: Diabetic patients with endometrial cancer had more lymph node metastasis than non-diabetic patients with endometrial cancer. L1 cell adhesion molecule (L1CAM) could be possibly associated with lymph node metastasis in diabetic patients with endometrial cancer via epithelial-mesenchymal transition. We aimed to investigate the association between L1CAM expression and lymph node metastasis in diabetic patients with endometrial cancer.
Methods: We conducted a matched case control study of 68 endometrial cancer patients who comprise each 34 diabetic and non-diabetic patients. L1CAM expression was evaluated by immunohistochemistry using fresh formalin-fixed paraffin-embedded tissue block of the patients. The association between L1CAM expression and pelvic lymph node metastasis was assessed according to the presence of diabetes.
Results: Of the 68 patients, 13 (19.1%) were positive for L1CAM immunostaining. Positive rate of L1CAM expression in diabetic endometrial cancer patients was similar to that in non-diabetic endometrial cancer patients (14.7% vs. 23.5%, P = 0.355). Tumor recurred more frequently in patients with positive L1CAM expression than those with negative L1CAM expression (33.3% vs. 1.6%, P = 0.019). However, we failed to find any significant association between L1CAM expression and lymph node metastasis. Only for the diabetic patients (n = 34), patients with pelvic lymph node metastasis had more L1CAM expression than those without lymph node metastasis (50.0% vs. 3.6%, P = 0.035). Advanced stage was the only risk factor for recurrence that showed a significant association with L1CAM expression for the diabetic endometrial cancer patients (P = 0.006), as well as all the enrolled patients (P = 0.014).
Conclusion: L1CAM expression is associated with pelvic lymph node metastasis and advanced stage in diabetic patients with endometrial cancer.

번역하기

참고문헌 (Reference)

1 Huszar M, "Up-regulation of L1CAM is linked to loss of hormone receptors and E-cadherin in aggressive subtypes of endometrial carcinomas" 220 : 551-561, 2010

2 Geismann C, "Up-regulation of L1CAM in pancreatic duct cells is transforming growth factor beta1- and slug-dependent: role in malignant transformation of pancreatic cancer" 69 : 4517-4526, 2009

3 Shergill IS, "Tissue microarrays: a current medical research tool" 20 : 707-712, 2004

4 Jawhar NM, "Tissue microarray: a rapidly evolving diagnostic and research tool" 29 : 123-127, 2009

5 Zecchini S, "The differential role of L1 in ovarian carcinoma and normal ovarian surface epithelium" 68 : 1110-1118, 2008

6 Hills CE, "TGF-beta1-induced epithelial-to-mesenchymal transition and therapeutic intervention in diabetic nephropathy" 31 : 68-74, 2010

7 Chung HH, "Role of integrated PET-CT in pelvic lymph node staging of cervical cancer before radical hysterectomy" 67 : 61-66, 2009

8 Holian J, "Role of Kruppel-like factor 6 in transforming growth factor-beta1-induced epithelial-mesenchymal transition of proximal tubule cells" 295 : F1388-F1396, 2008

9 Pecorelli S, "Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium" 105 : 103-104, 2009

10 Kang S, "Preoperative identification of a low-risk group for lymph node metastasis in endometrial cancer: a Korean gynecologic oncology group study" 30 : 1329-1334, 2012